A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies

Name: A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies
License: Public Domain

Beijing GoBroad Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

t-cell acute lymphocytic leukemia, acute lymphoblastic leukemia, in relapse, refractory acute lymphoblastic leukemia, t-cell malignancies

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 314331
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.